A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

Abroad (travel likely)RecruitingPHASE2

Conditions

Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clinical Trial Site, Lake Forest, California, United States
Clinical Trial Site, Tampa, Florida, United States
Clinical Trial Site, Savannah, Georgia, United States

Study leads

Medical Director
Study Director
Alnylam Pharmaceuticals

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease · Hypertension · High Cardiovascular Risk

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.

Pulmonary Arterial Hypertension PAH

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China · Beijing, China

Endocalyx in Treatment Resistent Hypertension

Treatment Resistant Hypertension

Abroad (travel likely)RecruitingPHASE2

Amsterdam, Netherlands

A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Abroad (travel likely)RecruitingPHASE1

Minneapolis, United States